Demographic Disparities in Diagnosis and Treatment of Anxiety and Depressive Disorders in Head and Neck Cancer Survivors.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 39925181.
- Also identified by DOI 10.1002/hed.28103 and PMC identifier 12146807.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The associations between head and neck cancer (HNC) and anxiety and depression are well-known, but knowledge regarding the association between demographic factors and rates of diagnosis and treatment for these disorders among HNC survivors is incomplete. This retrospective study utilized propensity score matching to compare rates of selected new anxiety and/or depressive disorder diagnoses among HNC survivors and treatment of those disorders by sex, race, ethnicity, and language. Results suggested lower likelihood of anxiety and/or depressive disorder diagnosis among individuals of male sex, and any minority, African American, Asian, and Other race, while diagnosis rates were higher among native Hawaiian/Pacific Islanders. Treatment with pharmacotherapy was less likely among individuals of male sex, any minority and African American Asian race, Hispanic ethnicity, and Spanish language. This study suggests that mental health diagnosis and treatment among HNC survivors may be inequitable, although further research is necessary to confirm these associations and understand underlying mechanisms.
Medical subject headings
- Head and Neck Neoplasms
- Cancer Survivors
- Depressive Disorder
- Anxiety Disorders
- Healthcare Disparities